- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 12.06. | NewGenIVF Group Limited: NewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate Market | 1 | GlobeNewswire (USA) | ||
| 04.06. | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 428 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
| 02.06. | NewGenIvf Plans To Invest $30 Mln In Solana | 2 | RTTNews | ||
| 02.06. | NewGenIvf to invest $30M in Solana staking; shares up | 3 | Seeking Alpha | ||
| 02.06. | NewGenIVF Group Limited: NewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset Staking | 177 | GlobeNewswire (Europe) | BANGKOK, June 02, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 02.06. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
| 20.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 01.05. | NewGenIvf kündigt Aktienzusammenlegung im Verhältnis 1:10 an | 3 | Investing.com Deutsch | ||
| 01.05. | NewGenIvf announces 1-for-10 reverse stock split | 1 | Investing.com | ||
| 01.05. | NewGenIVF Group Limited: NewGenIVF Announces Reverse Stock Split | 109 | GlobeNewswire (Europe) | BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
| 01.05. | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 29.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 22.04. | NewGenIVF Group Limited: NewGen Filed 2024 Annual Report on Form 20-F | 2 | GlobeNewswire (USA) | ||
| 22.04. | NewGenIvf Group Ltd - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 11.04. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 03.04. | NewGenIvf Stock Jumps 7% On Strategic Funding News | 2 | RTTNews | ||
| 03.04. | What's Going On With NewGenIvf Shares Thursday? | 1 | Benzinga.com | ||
| 03.04. | NewGenIVF Group Limited: NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth | 4 | GlobeNewswire (USA) |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,106 | +0,95 % | Research Capital analyst Andre Uddin keeps "Speculative Buy" rating on Sernova Biotherapeutics | ||
| ATOSSA THERAPEUTICS | 0,704 | -1,40 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,842 | -3,48 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,005 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,226 | -3,42 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,580 | +1,22 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| CYTOSORBENTS | 1,002 | -17,87 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,787 | -7,74 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 3,100 | +2,65 % | Ekso Bionics Stock Dips 4% Despite AI Integration Milestone | ||
| IMUNON | 0,755 | -1,31 % | Imunon, Inc.: IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025 | ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism... ► Artikel lesen | |
| BEYOND AIR | 0,158 | -0,63 % | Beyond Air, Inc. - 10-K, Annual Report | ||
| AVINGER | 0,340 | -6,08 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,480 | -2,14 % | Novacyt S.A. - Result of AGM | ||
| AROVELLA THERAPEUTICS | 0,051 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Notice Under Section 708A |
Das Unternehmen NEWGENIVF GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,040 (-3,70 %) liegt der Kurs bei 1,040 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEWGENIVF GROUP LIMITED finden Sie auf Wallstreet Online.